Filing Details

Accession Number:
0000914190-12-000433
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-19 17:46:21
Reporting Period:
2012-07-18
Filing Date:
2012-07-19
Accepted Time:
2012-07-19 17:46:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1427556 E James Flaherty 651 Campus Drive
St. Paul MN 55112
Chief Administrative Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-18 2,315 $9.80 118,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.83 2016-12-18 9,381 9,381 Direct
Common Stock Stock Option (right to buy) $8.83 2017-04-17 25,233 25,233 Direct
Common Stock Stock Option (right to buy) $7.90 2017-08-06 22,645 22,645 Direct
Common Stock Stock Option (right to buy) $12.15 2017-12-11 32,350 32,350 Direct
Common Stock Stock Option (right to buy) $8.75 2019-03-02 10,999 10,999 Direct
Common Stock Stock Option (right to buy) $9.28 2014-11-15 4,852 4,852 Direct
Common Stock Stock Option (right to buy) $12.37 2015-06-30 16,175 16,175 Direct
Common Stock Stock Option (right to buy) $12.37 2015-11-07 7,764 7,764 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-12-18 9,381 9,381 Direct
2017-04-17 25,233 25,233 Direct
2017-08-06 22,645 22,645 Direct
2017-12-11 32,350 32,350 Direct
2019-03-02 10,999 10,999 Direct
2014-11-15 4,852 4,852 Direct
2015-06-30 16,175 16,175 Direct
2015-11-07 7,764 7,764 Direct
Footnotes
  1. In connection with the vesting and delivery of restricted stock, and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2012, shares were sold and the net proceeds were used to pay required withholding taxes.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.58 to $10.14 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 632 shares acquired through the Issuer's Employee Stock Purchase Plan on December 31, 2011 and 679 shares acquired through the Issuer's Employee Stock Purchase Plan on June 30, 2012.
  4. Fully exercisable.